Please use this identifier to cite or link to this item:
Title: Updates on AAA screening and surveillance
Austin Authors: Chuen, Jason ;Theivendran, Mayo
Affiliation: Austin Health, Heidelberg, Victoria, Australia
Department of Surgery, Faculty of Medicine, Dentistry and Human Sciences, The University of Melbourne, Vic, Australia
North Shore Private, Sydney, NSW, Australia
St Vincent's Private, Sydney, NSW, Australia
the Northern Beaches Hospital, Sydney, NSW, Australia
Issue Date: May-2018
Publication information: Australian Journal of General Practice 2018; 47(5):259-263
Abstract: BACKGROUND: Screening and diagnostic surveillance of latent conditions have a profound impact on public healthcare expenditure and clinical outcomes. Abdominal aortic aneurysm (AAA) remains one of the hallmark pathologies in vascular surgery and an area of intense research interest. OBJECTIVE: This article is the second of two that will outline current areas of controversy and research in AAA disease in order to support a more detailed understanding of issues in managing patients with this condition, and inform the development of Australasian clinical guidelines and health policy. DISCUSSION: Screening and surveillance of AAA should be evidence-based and follow clinical guidelines; however, advances in treatment technology and epidemiological data have influenced results. Goals of care and cost‑effectiveness should play central parts in screening and surveillance strategies.
ORCID: 0000-0002-0955-5446
Journal: Australian Journal of General Practice
PubMed URL:
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on May 30, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.